{rfName}
NO

Indexed in

License and use

Citations

Altmetrics

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Pascual, T.AuthorPare, L.AuthorGalvan, P.AuthorRodríguez, A.AuthorChic, N.AuthorCejalvo, J. M.AuthorAdamo, B.AuthorVidal, M.AuthorMuñoz, M.AuthorPrat, A.Author
Share
Publications
>
Meeting Abstract

NOLUS: a predictive model to identify Basal-like and HER2-enriched intrinsic subtypes based on estrogen receptor (ER), progesterone receptor (PR) and Ki67 immunohistochemistry (IHC) in hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC)

Publicated to:European Journal Of Cancer. 92 S138-S138 - 2018-04-01 92(), DOI: 10.1016/S0959-8049(18)30638-5

Authors: Pascual, T; Martin, M; Pare, L; Alba, E; Rodriguez-Lescure, A; Perrone, G; Cortes, J; Morales, S; Lluch, A; Urruticoechea, A; Galvan, P; Rodriguez, A; Chic, N; Righi, D; Cejalvo, J M; Tonini, G; Adamo, B; Vidal, M; Munoz, M; Prat, A

Affiliations

Biomed Res Inst INCLIVA, Grp Invest Biol Canc Mama, Valencia, Spain - Author
CIBERONC ISCIII, Ctr Invest Biomed Red Oncol, Madrid, Spain - Author
Fdn Onkol, Dept Med Oncol, Donostia San Sebastian, Spain - Author
Hosp Arnau Vilanova, Lleida, Spain - Author
Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain - Author
Hosp Clin Univ, Dept Med Oncol, Valencia, Spain - Author
Hosp Gregorio Maranon, Dept Med Oncol, Madrid, Spain - Author
Hosp Univ Elche, Dept Med Oncol, Elche, Spain - Author
Hosp Univ Virgen de la Victoria, IBIMA, Med Oncol Deparment, Malaga, Spain - Author
IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumors, Barcelona, Spain - Author
Ramon y Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain - Author
Spanish Breast Canc Grp, GEICAM, Madrid, Spain - Author
Univ Campus Biomed Roma, Dept Med Oncol, Rome, Italy - Author
Univ Campus Biomed Roma, Dept Med, Rome, Italy - Author
Univ Complutense, Deparment Med, Madrid, Spain - Author
See more

Abstract

Keywords
Good health and well-being

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal European Journal Of Cancer due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2018, it was in position 26/230, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-16:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 2 (PlumX).
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 3 - Good Health And Well-being, with a probability of 63% according to the mBERT algorithm developed by Aurora University.
Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Italy.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Pascual Martínez, Tomas) and Last Author (Prat Aparicio, Aleix).